Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Curr Pediatr Rev ; 16(2): 148-155, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-31951184

RESUMEN

Infants born prematurely (before completion of 37 weeks of gestation) are at increased risk of morbidity and mortality due to vaccine preventable diseases, mostly because of their immunological immaturity and failure of transfer of maternal protective antibodies. Despite their great need of being vaccinated, concerns on vaccine safety and efficacy, constitute the main reasons for which vaccinations are often delayed in this group. In this review we summarize the latest evidence on vaccine safety, efficacy and immunogenicity in preterm infants which is similar to full-term infants. Therefore there is no reason for delaying vaccination in this population.


Asunto(s)
Enfermedades del Prematuro/prevención & control , Vacunación/efectos adversos , Vacunación/métodos , Vacunas/administración & dosificación , Vacunas/efectos adversos , Virosis/prevención & control , Factores de Edad , Humanos , Recién Nacido , Recien Nacido Prematuro , Enfermedades del Prematuro/inmunología , Seguridad del Paciente , Vacunas/inmunología , Virosis/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA